A leading Indian IT solutions provider has announced Melbourne to set up its Australia and New Zealand headquarters, creating new jobs and providing integrated IT solutions to businesses across the region.
Developers of the Pfizer/BioNTech Covid-19 mRNA vaccine have chosen Victoria to establish their Asia-Pacific mRNA clinical research and development centre, paving the way for future medical breakthroughs.
European electric bus developer Ebusco has announced Melbourne to set up its Asia Pacific headquarters, with the launch of its Ebusco 2.2 battery electric bus for right hand drive markets including Australia, New Zealand and Japan.
Renowned global games development company Keywords Studios PLC is once again investing in Victoria, establishing its Centre of Excellence in Melbourne.
A Singaporean healthtech leader that has created a tech solution to connect cancer patients, hospitals and industry in real time will establish its Australian headquarters in Melbourne.
Victorian startup Kite Magnetics is getting a major boost, with an investment announcement from the $2 billion Breakthrough Victoria fund.
New-Zealand-based games company A44, renowned for its sophisticated visual effects and lifelike gameplay, has chosen Melbourne for its Australian headquarters.
Global leader in aviation Bombardier has chosen to open its new operations headquarters in Victoria, marking an important gateway to the Asia-Pacific region.
A new global tech unicorn has chosen Victoria to open its Oceania office, bringing new jobs and opportunities for Victorian universities and graduates.
Data from global investment consultant fDi Markets shows Victoria attracted $8.1 billion in overseas investment in 2021-22, well ahead of New South Wales ($6.1 billion) and Western Australia ($5.8 billion).
A critical minerals startup, Magnium Australia is conducting a groundbreaking feasibility study that could lead to the world’s first net-zero magnesium foundry being built in Victoria with technology developed by the CSIRO.
A Pandemic Therapeutics Centre will be established in Melbourne to rapidly develop new life-saving treatments, further expanding on Melbourne’s reputation as a global leader in medical research.